Bronchodilator reversibility in asthma and COPD: Findings from three large population studies
<br/>Bronchodilator response (BDR) testing is used as a diagnostic method in obstructive airway diseases. The aim of this investigation was to compare different methods for measuring BDR in participants with asthma and COPD and to study to the extent to which BDR was related to symptom burden...
Main Authors: | Janson, C, Malinovschi, A, Amaral, A, Accordini, S, Bousquet, J, Sonia Buist, A, Canonica, G, Dahlén, B, Garcia-Aymerich, J, Gnatiuc, L, Kowalski, M, Patel, J, Tan, W, Torén, K, Zuberbier, T, Burney, P, Jarvis, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
European Respiratory Society
2019
|
Similar Items
-
Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
by: Barjaktarevic I, et al.
Published: (2018-10-01) -
Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters
by: Kraemer R, et al.
Published: (2021-09-01) -
Can spirometric norms be set using pre- or post- bronchodilator test results in older people?
by: Kato Bernet, et al.
Published: (2012-11-01) -
Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review
by: Almeshari MA, et al.
Published: (2021-11-01) -
COPD - moving beyond bronchodilation
by: Swiss Medical Weekly
Published: (2007-03-01)